Cellectar Biosciences (CLRB) Institutional Ownership $0.31 -0.02 (-6.10%) Closing price 02/21/2025 03:58 PM EasternExtended Trading$0.30 -0.01 (-2.87%) As of 02/21/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cellectar Biosciences (NASDAQ:CLRB)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$11.12MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$6.00M Get CLRB Insider Trade Alerts Want to know when executives and insiders are buying or selling Cellectar Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CLRB Institutional Buying and Selling by Quarter Cellectar Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Squarepoint Ops LLC520,240$156K0.0%N/A1.129% 2/17/2025 Bank of America Corp DE206,783$62K0.0%+25.3%0.449% 2/13/2025 ADAR1 Capital Management LLC585,261$175K0.0%-42.7%1.270% 2/12/2025 JPMorgan Chase & Co.182,403$55K0.0%+687.3%0.396% 11/19/2024 Barclays PLC120,497$258K0.0%-30.0%0.292% 11/16/2024 Geode Capital Management LLC352,452$754K0.0%+3.3%0.869% 11/15/2024 Barclays PLC120,497$258K0.0%-30.0%0.297% 11/15/2024 XTX Topco Ltd53,022$113K0.0%-16.2%0.131% 11/6/2024 Oppenheimer & Co. Inc.12,500$27K0.0%N/A0.031% 10/30/2024 Rosalind Advisors Inc.3,671,550$7.86M4.9%+35.7%10.241% Get the Latest News and Ratings for CLRB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cellectar Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024 Sequoia Financial Advisors LLC23,800$51K0.0%N/A0.066% 8/20/2024 Nantahala Capital Management LLC1,833,325$4.58M0.3%-2.1%5.114% 8/16/2024 Coastal Bridge Advisors LLC11,000$28K0.0%-31.3%0.031% 8/12/2024 XTX Topco Ltd63,304$158K0.0%+432.4%0.177% 8/7/2024 AIGH Capital Management LLC3,036,187$7.59M2.4%+8.2%8.469% 7/12/2024 Rosalind Advisors Inc.2,705,616$6.76M5.0%+335.4%7.547% 5/10/2024 Vanguard Group Inc.1,191,081$4.74M0.0%+146.7%3.322% 4/25/2024 Rosalind Advisors Inc.621,478$2.47M2.3%-69.0%1.926% 2/14/2024 ADAR1 Capital Management LLC1,378,082$3.82M1.4%N/A11.213% 2/12/2024 AIGH Capital Management LLC1,915,220$5.31M2.1%+182.7%15.584% 2/9/2024 Worth Venture Partners LLC693,909$1.92M1.0%+148.6%5.646% 1/1/2024 Vanguard Group Inc.175,884$464K0.0%+2.3%1.431% 11/15/2023 Worth Venture Partners LLC279,123$737K0.4%-11.0%2.808% 11/15/2023 Acuta Capital Partners LLC121,300$320K0.2%N/A1.220% 11/13/2023 AIGH Capital Management LLC677,511$1.79M0.8%-16.7%6.816% 7/21/2023 1900 Wealth Management LLC18,000$35K0.0%+50.0%0.185% 2/16/2023 AIGH Capital Management LLC931,888$1.59M0.5%+434.3%9.924% 11/16/2022 Maven Securities LTD25,000$84K0.0%-93.8%0.266% 11/14/2022 Worth Venture Partners LLC41,636$140K0.1%-90.9%0.444% 11/14/2022 Maven Securities LTD25,000$84K0.0%-93.8%0.266% 11/3/2022ACT Capital Management LLC21,750$73K0.1%-90.0%0.356% 10/31/2022 1900 Wealth Management LLC12,000$40K0.0%N/A0.196% 5/12/2022 AIGH Capital Management LLC1,837,046$1.26M0.3%+104.9%3.007% 4/27/2022 1900 Wealth Management LLC120,000$83K0.0%+100.0%0.196% 2/14/2022 Maven Securities LTD400,000$266K0.0%-60.4%0.655% 2/10/2022 AIGH Capital Management LLC896,590$596K0.2%N/A1.467% 11/15/2021 Franklin Resources Inc.142,400$132K0.0%N/A0.233% 11/12/2021 Renaissance Technologies LLC447,074$414K0.0%-55.8%0.732% 11/5/2021 Cozad Asset Management Inc.51,000$47K0.0%+64.5%0.083% 9/17/2021 Virtu Financial LLC49,780$59K0.0%N/A0.081% Watch This Robotics Demo Before March 17th (Ad)Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry." Click here to watch the demo…8/17/2021PVG Asset Management Corp193,510$230K0.7%+1,804.6%0.317% 8/16/2021 Maven Securities LTD650,000$793K0.0%-27.8%1.064% 8/16/2021 State Street Corp147,846$176K0.0%N/A0.242% 8/16/2021 Sabby Management LLC426,561$508K0.1%+9.6%0.698% 8/13/2021 Renaissance Technologies LLC1,011,268$1.20M0.0%+13.3%1.655% 8/13/2021QS Investors LLC142,400$170K0.0%N/A0.233% 8/13/2021 Geode Capital Management LLC397,170$472K0.0%+62.5%0.650% 8/13/2021 Vanguard Group Inc.1,874,584$2.23M0.0%+14.1%3.068% 8/5/2021 GSA Capital Partners LLP297,653$354K0.0%+90.0%0.564% 8/4/2021 Envestnet Asset Management Inc.104,385$124K0.0%+354.3%0.198% 8/2/2021 Advisor Group Holdings Inc.23,827$28K0.0%+221.4%0.045% 8/1/2021 Sterneck Capital Management LLC30,000$34K0.0%N/A0.057% 7/29/2021 Cozad Asset Management Inc.31,000$37K0.0%+181.8%0.059% 5/19/2021 Squarepoint Ops LLC136,942$220K0.0%N/A0.260% 5/18/2021 Millennium Management LLC246,485$397K0.0%+1,249.3%0.467% 5/18/2021 Silverarc Capital Management LLC606,358$976K0.5%-65.8%1.150% 5/14/2021 Dimensional Fund Advisors LP21,265$34K0.0%-33.8%0.040% 5/13/2021 Renaissance Technologies LLC892,557$1.44M0.0%+229.5%1.693% 5/12/2021 Northern Trust Corp95,438$154K0.0%+114.8%0.181% 5/12/2021 Geode Capital Management LLC244,392$393K0.0%+84.6%0.464% 5/10/2021 GSA Capital Partners LLP156,696$252K0.0%N/A0.297% 5/4/2021 Envestnet Asset Management Inc.22,979$37K0.0%+87.4%0.045% 5/4/2021 Commonwealth Equity Services LLC22,945$36K0.0%+48.8%0.045% 4/30/2021 Creative Planning30,000$48K0.0%N/A0.059% 3/8/2021 Dimensional Fund Advisors LP32,146$67K0.0%N/A0.064% 2/25/2021 Dimensional Fund Advisors LP32,146$67K0.0%N/A0.071% 2/24/2021 Virtu Financial LLC226,837$472K0.1%N/A0.499% 2/16/2021 Silverarc Capital Management LLC1,772,848$3.69M2.1%N/A3.901% 2/16/2021 Tri Locum Partners LP658,373$1.37M0.5%N/A1.449% 2/16/2021 Prelude Capital Management LLC130,208$271K0.0%N/A0.286% 2/10/2021 Renaissance Technologies LLC270,865$563K0.0%-38.6%0.596% 2/9/2021 Bank of New York Mellon Corp31,709$66K0.0%N/A0.070% 2/5/2021BlackRock Inc.709,909$1.48M0.0%+1,203,135.6%1.562% (Data available from 1/1/2016 forward) CLRB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CLRB shares? During the previous two years, 17 institutional investors and hedge funds held shares of Cellectar Biosciences. The most heavily invested institutionals were Rosalind Advisors Inc. ($7.86M), AIGH Capital Management LLC ($7.59M), Vanguard Group Inc. ($4.74M), Nantahala Capital Management LLC ($4.58M), Worth Venture Partners LLC ($1.92M), Geode Capital Management LLC ($754K), and Acuta Capital Partners LLC ($320K).Learn more on CLRB's institutional investors. What percentage of Cellectar Biosciences stock is owned by institutional investors? 16.41% of Cellectar Biosciences stock is owned by institutional investors. Learn more on CLRB's institutional investor holdings. Which institutional investors have been buying Cellectar Biosciences stock? Of the 14 institutional investors that purchased Cellectar Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rosalind Advisors Inc. ($3.05M), AIGH Capital Management LLC ($1.47M), ADAR1 Capital Management LLC ($1.38M), Vanguard Group Inc. ($712.10K), Squarepoint Ops LLC ($520.24K), Worth Venture Partners LLC ($414.79K), and JPMorgan Chase & Co. ($159.23K). How much institutional buying is happening at Cellectar Biosciences? Institutional investors have bought a total of 7,971,478 shares in the last 24 months. This purchase volume represents approximately $19.86M in transactions. Which Cellectar Biosciences major shareholders have been selling company stock? The following institutional investors have sold Cellectar Biosciences stock in the last 24 months: Rosalind Advisors Inc. ($1.38M), ADAR1 Capital Management LLC ($436.90K), AIGH Capital Management LLC ($135.69K), Barclays PLC ($103.40K), Nantahala Capital Management LLC ($40K), Worth Venture Partners LLC ($34.39K), and XTX Topco Ltd ($10.28K). How much institutional selling is happening at Cellectar Biosciences? Institutional investors have sold a total of 2,149,834 shares in the last 24 months. This volume of shares sold represents approximately $6.44M in transactions. Related Companies PRLD Major Shareholders KALA Major Shareholders CNTB Major Shareholders CELU Major Shareholders XLO Major Shareholders DYAI Major Shareholders ALVR Major Shareholders ATRA Major Shareholders OSTX Major Shareholders OVID Major Shareholders This page (NASDAQ:CLRB) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellectar Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellectar Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.